2m 2m 2m 2m 2m 2m 2m
CYTEK BIOSCI (CTKB)
NASDAQ
$4.37+$0.15 (+3.58%)
Price as of Aug 03, 2026 8:31 AM EDT- $545.0MMarket Cap
- 15.93%1-Year Change
- Medical DevicesIndustry
CYTEK BIOSCI (CTKB)
$4.37+$0.15 (+3.58%)
CTKB | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $4.22 | ||
Change | -$0.09 (-2.09%) | ||
Open | $4.28 | ||
High | $4.31 | ||
Low | $4.13 | ||
Previous Close | $4.31 | ||
Volume | 608,894 | ||
30-Day Average Volume | 786,606 | ||
1-Week Change | -5.38% | ||
1-Month Change | -4.74% | ||
1-Year Change | 15.93% | ||
3-Year Change | -52.90% | ||
5-Year Change | -80.97% | ||
Fundamentals | |||
Shares Outstanding | 129.1M | ||
Total Assets | $449.1M | ||
Market Cap | $545.0M | ||
Enterprise Value | $481.3M | ||
Period: QTR TTM FY | |||
Revenue | $28.8M | ||
Net Income | -$18.9M | ||
Free Cash Flow | -$4.9M | ||
EBIT | -$17.4M | ||
EBITDA | -$15.5M | ||
Net Working Capital | $298.4M | ||
EPS | N/A | ||
Enterprise Value/EBITDA | -31 | ||
Enterprise Value/Revenue | 17 | ||
P/B | 2 | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | -111 | ||
Price/Operating Cash Flow | -199 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue